These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cyclosporine-induced hyperuricemia after renal transplant: clinical characteristics and mechanisms. Ahn KJ; Kim YS; Lee HC; Park K; Huh KB Transplant Proc; 1992 Aug; 24(4):1391-2. PubMed ID: 1496597 [No Abstract] [Full Text] [Related]
9. The incidence of gout in renal transplant recipients. West C; Carpenter BJ; Hakala TR Am J Kidney Dis; 1987 Nov; 10(5):369-72. PubMed ID: 3314490 [TBL] [Abstract][Full Text] [Related]
10. Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month. Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J Transplant Proc; 1994 Oct; 26(5):2944-8. PubMed ID: 7940929 [No Abstract] [Full Text] [Related]
11. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients. Roth D; Miller J Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204 [No Abstract] [Full Text] [Related]
12. Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Burack DA; Griffith BP; Thompson ME; Kahl LE Am J Med; 1992 Feb; 92(2):141-6. PubMed ID: 1543197 [TBL] [Abstract][Full Text] [Related]
13. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Kanbay M; Akcay A; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M Transplant Proc; 2005 Sep; 37(7):3119-20. PubMed ID: 16213325 [TBL] [Abstract][Full Text] [Related]
14. Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature. Pilmore HL; Faire B; Dittmer I Transplantation; 2001 Nov; 72(10):1703-5. PubMed ID: 11726837 [TBL] [Abstract][Full Text] [Related]
15. The influence of cold ischemia and donor age on renal allograft outcome in the cyclosporine era. Cacciarelli TV; Sumrani N; DiBenedetto A; Hong JH; Sommer BG Transplant Proc; 1992 Oct; 24(5):2044-5. PubMed ID: 1412966 [No Abstract] [Full Text] [Related]
16. Tubular effects of cyclosporine in pediatric renal transplant recipients. Laine J; Holmberg C Transplant Proc; 1996 Aug; 28(4):2104-6. PubMed ID: 8769167 [No Abstract] [Full Text] [Related]
17. Kidney function in cyclosporine-treated pediatric heart transplant recipients. Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133 [TBL] [Abstract][Full Text] [Related]
18. Treatment of gout after transplantation. Perez-Ruiz F; Alonso-Ruiz A; Calabozo M; Duruelo J Br J Rheumatol; 1998 May; 37(5):580. PubMed ID: 9651090 [No Abstract] [Full Text] [Related]
19. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus. Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511 [TBL] [Abstract][Full Text] [Related]
20. Cyclosporin induced hyperuricemia and gout. Deray G; Assogba U; Le Hoang P; Brillet G; Baumelou B; Ben Hmida M; Jacobs C Clin Nephrol; 1990 Mar; 33(3):154. PubMed ID: 2323116 [No Abstract] [Full Text] [Related] [Next] [New Search]